Cleared Traditional

K090301 - BINAXNOW PBP2A TEST, MODEL 890-000
(FDA 510(k) Clearance)

Apr 2010
Decision
432d
Days
Class 2
Risk

K090301 is an FDA 510(k) clearance for the BINAXNOW PBP2A TEST, MODEL 890-000. This device is classified as a System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies (Class II - Special Controls, product code MYI).

Submitted by Binax, Inc. (Scarborough, US). The FDA issued a Cleared decision on April 14, 2010, 432 days after receiving the submission on February 6, 2009.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1640.

Submission Details

510(k) Number K090301 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 2009
Decision Date April 14, 2010
Days to Decision 432 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code MYI — System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1640

Similar Devices — MYI System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies

All 9
MECA XPRESSFISH
K140619 · Advandx, Inc. · Oct 2014
ALERE PBP2A SA/CONS CULTURE COLONY TEST
K133851 · Alere Scarborough, Inc. · Sep 2014
ALERE PBP2A TEST
K121905 · Alere Scarborough, Inc. · Jul 2012
CLEARVIEW EXACT PBP2A TEST, MODEL 891-000
K091766 · Binax, Inc. · Feb 2010
MASTALEX -MRSA, MODEL RST501
K062864 · Mast Group , Ltd. · Oct 2006
OXOID PBP2 1 LATEX AGGLUTINATION TEST
K011710 · Oxoid , Ltd. · Apr 2002